Evidence map›Paper›PMID 38166129›Full record

ArticlePLoS neglected tropical diseases2024

Pyrethroid susceptibility reversal in Aedes aegypti: A longitudinal study in Tapachula, Mexico.

Patricia Penilla-Navarro, Francisco Solis-Santoyo, Alma Lopez-Solis, Americo D Rodriguez, Farah Vera-Maloof, Saul Lozano, Elsa Contreras-Mejía, Geovanni Vázquez-Samayoa, Rene Torreblanca-Lopez, Rushika Perera and 2 more

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Patricia Penilla-NavarroCentro Regional de Investigación en Salud Pública, Instituto Nacional de Salud Pública, Tapachula, Chiapas, México.
Francisco Solis-SantoyoCentro Regional de Investigación en Salud Pública, Instituto Nacional de Salud Pública, Tapachula, Chiapas, México.
Alma Lopez-SolisCentro Regional de Investigación en Salud Pública, Instituto Nacional de Salud Pública, Tapachula, Chiapas, México.
Americo D RodriguezCentro Regional de Investigación en Salud Pública, Instituto Nacional de Salud Pública, Tapachula, Chiapas, México.
Farah Vera-MaloofCentro Regional de Investigación en Salud Pública, Instituto Nacional de Salud Pública, Tapachula, Chiapas, México.
Saul LozanoCenters for Disease Control and Prevention, Arboviral Diseases Branch, Fort Collins, Colorado.
Elsa Contreras-MejíaJurisdiccion Sanitaria VII, Tapachula Chiapas, Antiguo Hospital General de Tapachula, Tapachula, Chiapas, Mexico.
Geovanni Vázquez-SamayoaJurisdiccion Sanitaria VII, Tapachula Chiapas, Antiguo Hospital General de Tapachula, Tapachula, Chiapas, Mexico.
Rene Torreblanca-LopezJurisdiccion Sanitaria VII, Tapachula Chiapas, Antiguo Hospital General de Tapachula, Tapachula, Chiapas, Mexico.
Rushika PereraCenter for Vector-Borne Infectious Diseases, Colorado State University, 1685 Campus Delivery, Fort Collins, Colorado.
William C Black IvCenter for Vector-Borne Infectious Diseases, Colorado State University, 1685 Campus Delivery, Fort Collins, Colorado.
Karla Saavedra-RodriguezCenter for Vector-Borne Infectious Diseases, Colorado State University, 1685 Campus Delivery, Fort Collins, Colorado.ORCID 0000-0001-8511-3327
Instituto Nacional de Salud Pública · MXColorado State University · USUniversidad del Tacana · MXCenters for Disease Control and Prevention · US

Funding

Insecticide Resistance Management to Preserve Pyrethroid Susceptibility in Aedes aegyptiR01AI121211 · NIAID · COLORADO STATE UNIVERSITY · PI SAAVEDRA RODRIGUEZ, KARLA LIZET · 2016 to 2020
$1.7M
NIAID NIH HHS R01 AI121211
6 · The paper itself

Abstract

Pyrethroid resistance in Aedes aegypti has become widespread after almost two decades of frequent applications to reduce the transmission of mosquito-borne diseases. Because few insecticide classes are available for public health use, insecticide resistance management (IRM) is proposed as a strategy to retain their use. A key hypothesis of IRM assumes that negative fitness is associated with resistance, and when insecticides are removed from use, susceptibility is restored. In Tapachula, Mexico, pyrethroids (PYRs) were used exclusively by dengue control programs for 15 years, thereby contributing to selection for high PYR resistance in mosquitoes and failure in dengue control. In 2013, PYRs were replaced by organophosphates-insecticides from a class with a different mode of action. To test the hypothesis that PYR resistance is reversed in the absence of PYRs, we monitored Ae. aegypti's PYR resistance from 2016 to 2021 in Tapachula. We observed significant declining rates in the lethal concentration 50 (LC50), for permethrin and deltamethrin. For each month following the discontinuation of PYR use by vector control programs, we observed increases in the odds of mosquitoes dying by 1.5% and 8.4% for permethrin and deltamethrin, respectively. Also, knockdown-resistance mutations (kdr) in the voltage-gated sodium channel explained the variation in the permethrin LC50s, whereas variation in the deltamethrin LC50s was only explained by time. This trend was rapidly offset by application of a mixture of neonicotinoid and PYRs by vector control programs. Our results suggest that IRM strategies can be used to reverse PYR resistance in Ae. aegypti; however, long-term commitment by operational and community programs will be required for success.

Indexed as

AedesDengueInsecticidesNitrilesPyrethrinsAnimalsHumansInsecticide ResistanceLongitudinal StudiesMexicoMosquito VectorsMutationPermethrindecamethrinInsecticidesNitrilesPermethrinPyrethrins

Identifiers

PMID38166129
PMCPMC10786364
OpenAlexW4390495190

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.